Body weight variation and control of cardiovascular risk factors in essential hypertension

Blood Pressure

Volumn 18, Issue 5, 2009, Pages 247-254

  Pascual, Jose Maria ^a,b   Rodilla, Enrique ^a,b   Costa, Jose Antonio ^a   Perez Lahiguera, Francisco ^a,b   Gonzalez, Carmen ^a   Lurbe, Empar ^b,c   Redón, Josep ^b,d  

^a HOSPITAL DE SAGUNTO   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Blood pressure control; Metabolic syndrome; Therapeutic goals; Weight variation

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SULFOSALICYLIC ACID; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY RISK; DIASTOLIC BLOOD PRESSURE; DIET; DISEASE CONTROL; DISEASE COURSE; ESSENTIAL HYPERTENSION; EXERCISE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT CHANGE;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIET; EXERCISE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; WEIGHT GAIN; WEIGHT LOSS;

EID: 70450159276     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08037050903244791     Document Type: Article

References (26)

1. De Backer G, A mbrosioni E, B orch-Johnsen K, B rotons C, Cifkova R, Dallongeville J, et al. ; European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2003;24:1601-1610.
2. Chobanian AV, B akris GL, B lack HR, C ushman WC, G reen LA, Izzo JL Jr, et al. ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560-2572.
3. Flegal KM, C arroll MD, Ogden CL, Johnson CL. P revalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288:1723-1727.
4. Grundy SM, C leeman JI, D aniels SR, D onato KA, E ckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome. Circulation. 2005;112:2735-2752.
5. Kannel WB. Risk stratifi cation in hypertension: New insights from the Framingham Study. Am J Hypertens. 2000;1:3S-10S.
6. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-13121
7. Genuth S, A lberti KG, Bennett P, B use J, D efronzo R, Kahn R, et al. ; Expert Committee on the Diagnosis and Classifi cation of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003; 26:3160-3167.
8. Clinical Guidelines on the Identifi cation, Evaluation, and Treatment of Overweight and Obesity in Adults - the Evidence Report. National Institutes of Health. Obes Res. 1998;6 Suppl 2 :51S-209S.
9. Fontaine KR, Redden DT, Wang C, W estfall AO, Allison DB. Years of life lost due to obesity. JAMA. 2003;289:187-193.
10. Modan M, A lmog S, F uchs Z, C hetrit A, Lusky A, H alkin H. Obesity, glucose intolerance, hyperinsulinemia, and response to antihypertensive drugs. Hypertension. 1991;17:565-573.
11. Petrie JC, O 'Brien ET, Littler WA, de Swiet M. Recommendations on blood pressure measurement. Br Med J. 1986; 293:611-615.
12. Levey AS, Bosch JP, L ewis JB, G reene T, Rogers N, R oth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
13. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al.; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: An American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-2752.
14. Rantala AO, K arma H, L ilja M, S avolainen MJ, R eunanen A, Kesaniemi YA. Prevalence of the metabolic syndrome in drugtreated hypertensive patients and control subjects. J Intern Med. 1999;245:163-174.
15. Bog-Hansen E, L indblad U, G ullberg B, M elander A, Rastam L. Metabolic disorders associated with uncontrolled hypertension. Diabetes Obes Metab. 2003;5:379-387.
16. Schillaci G, Pirro M, Vaudo G, Gemelli F, Marchesi S, Porcellati C, et al. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol. 2004;43: 1817-1822. (Pubitemid 38622521)
17. Martell N, Mateo J, Fernandez C, Fernandez-Cruz A, Luque-Otero M. Metabolic syndrome and insulin resistance in newly diagnosed hypertensives, treated hypertensives and normotensives. J Hypertens. 2004;22 Suppl 2 :s368(A).
18. Navarro J, R edon J, C ea-Calvo L, L ozano JV, F ernandez-Perez C, Bonet A, Gonzalez-Esteban J. Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA study. Blood Press. 2007;16: 20-27.
19. Mule G, N ardi E, C ottone S, C usimano P, V olpe V, P iazza G, et al. Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med. 2005;257:503-513.
20. Brown CD, Higgins M, D onato KA, Rohde FC, G arrison R, Obarzanek E, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res. 2000;8:605-619.
21. Must A, Spadano J, C oakley EH, F ield AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523-1529.
22. Huang Z, W illett WC, Manson JE, R osner B, Stampfer MJ, Speizer FE, et al. Body weight, weight change, and risk for hypertension in women. Ann Intern Med. 1998;128:81-88. (Pubitemid 28053128)
23. Stevens VJ, O barzanek E, C ook NR, L ee IM, Appel LJ, Smith West D, et al. ; Trials for the Hypertension Prevention Research Group. Long-term weight loss and changes in blood pressure: Results of the Trials of Hypertension Prevention, phase II. Ann Intern Med. 2001;134:1-11.
24. Davis BR, B laufox MD, O berman A, W assertheil-Smoller S, Zimbaldi N, Cutler JA, et al. Reduction in long-term antihypertensive medication requirements: Effects of weight reduction by dietary intervention in overweight persons with mild hypertension. Arch Intern Med. 1993;153: 1773-1782.
25. Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: A randomized controlled Trial of Nonpharmacologic Interventions in the Elderly (TONE). JAMA. 1998;279: 839-846.
26. Redon J, C ifkova R, L aurent S, N ilsson P, Narkiewicz K, Erdine S, Mancia G; Scientific Council of the European Society of Hypertension. The metabolic syndrome in hypertension: European Society of Hypertension Position Statement. J Hypertens. 2008;26:1891-1900